Evidence map›Paper›PMID 18544560›Full record

ReviewCarcinogenesis2008

Laboratory and clinical studies of cancer chemoprevention by antioxidants in berries.

Gary David Stoner, Li-Shu Wang, Bruce Cordell Casto

Open access · bronzeAbstract readReview
In one paragraph

Review in Carcinogenesis, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 204 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Review
  10. Edible Wild VegetablesPlants (Basel, Switzerland) · 2022
    Article
  11. Wild edible fruit cropJournal of food science and technology · 2022
    Article
  12. Article
  13. Bilberry (Antioxidants (Basel, Switzerland) · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gary David StonerDepartment of Internal Medicine, College of Medicine, The Ohio StateUniversity, Columbus, OH 43210, USA. gary.stoner@osumc.edu
Li-Shu Wang
Bruce Cordell Casto
The Ohio State University · US

Funding

Prevention of Esophageal Cancer with BerriesR01CA103180 · NCI · OHIO STATE UNIVERSITY · PI STONER, GARY · 2003 to 2013
$4.0M
NCI NIH HHS R01 CA103180
6 · The paper itself

Abstract

Reactive oxygen species (ROS) are a major cause of cellular injury in an increasing number of diseases, including cancer. Most ROS are created in the cell through normal cellular metabolism. They can be produced by environmental insults such as ultraviolet light and toxic chemicals, as well as by the inflammatory process. Interception of ROS or limiting their cellular effects is a major role of antioxidants. Due to their content of phenolic and flavonoid compounds, berries exhibit high antioxidant potential, exceeding that of many other foodstuffs. Through their ability to scavenge ROS and reduce oxidative DNA damage, stimulate antioxidant enzymes, inhibit carcinogen-induced DNA adduct formation and enhance DNA repair, berry compounds have been shown to inhibit mutagenesis and cancer initiation. Berry constituents also influence cellular processes associated with cancer progression including signaling pathways associated with cell proliferation, differentiation, apoptosis and angiogenesis. This review article summarizes laboratory and human studies, demonstrating the protective effects of berries and berry constituents on oxidative and other cellular processes leading to cancer development.

Indexed as

AnimalsAntioxidantsClinical Trials as TopicFruitHumansNeoplasmsOxidative StressReactive Oxygen SpeciesSignal TransductionAntioxidantsReactive Oxygen Species

Identifiers

PMID18544560
PMCPMC3246882
OpenAlexW2167674333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.